Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Describe Characteristics and Management of Patients With Postmenopausal Osteoporosis Treated With Prolia® in Routine Clinical Practice

NCT01652690 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01652690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Describe Characteristics and Management of Patients With Postmenopausal Osteoporosis Treated With Prolia® in Routine Clinical Practice
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 26, 2012
Completion date
May 15, 2015
Enrollment
600 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, postmenopausal